Title:
COMPOSITION FOR INTERNAL USE THAT INCLUDES PTEROSTILBENE GLYCOSIDE
Document Type and Number:
WIPO Patent Application WO/2018/034327
Kind Code:
A1
Abstract:
The present invention addresses the problem of providing a composition for internal use that actualizes an effect for preventing or improving wrinkles or sagging of the skin and/or a composition for internal use that actualizes a whitening effect. The problem is solved by providing a composition for internal use that includes pterostilbene glycoside.
Inventors:
HAMADA HIROKI (JP)
UESUGI DAISUKE (JP)
SHIMODA KEI (JP)
UESUGI DAISUKE (JP)
SHIMODA KEI (JP)
Application Number:
PCT/JP2017/029570
Publication Date:
February 22, 2018
Filing Date:
August 17, 2017
Export Citation:
Assignee:
TOMOIKE INDUSTRIAL H K LTD (CN)
International Classes:
A61K31/7034; A23L33/10; A61P17/00; A61P17/16; A23L2/52
Foreign References:
JP2014171436A | 2014-09-22 | |||
JP2015129112A | 2015-07-16 | |||
JP2013075851A | 2013-04-25 | |||
JP2013227275A | 2013-11-07 | |||
JP2013075850A | 2013-04-25 | |||
US20100240767A1 | 2010-09-23 | |||
KR20170034336A | 2017-03-28 | |||
JP6173543B1 | 2017-08-02 |
Other References:
SATO, D. ET AL.: "Synthesis of glycosides of resveratrol, pterostilbene, and piceatannol, and their anti-oxidant, anti-allergic, and neuroprotective activities", BIOSCIENCE, BIOTECHNOLOGY, AND BIOCHEMISTRY, vol. 78, no. 7, 2014, pages 1123 - 1128, XP055470270
ERIKO INUI ET AL.: "Development of ASTALIFT Renewal Products", FUJIFILM RESEARCH & DEVELOPMENT, vol. 58, 2013, pages 19 - 23, XP055470284
YOON, H. S. ET AL.: "Comparative Depigmentation Effects of Resveratrol and Its Two Methyl Analogues in -Melanocyte stimulating Hormone- Triggered B16/F10 Murine Melanoma Cells", PREV. NUTR. FOOD SCI., vol. 21, no. 2, 2016, pages 155 - 159, XP055470286, [retrieved on 20160630]
HAMADA, H. ET AL.: "Pterostilbene and Its Glucoside Induce Type XVII Collagen Expression", NATURAL PRODUCT COMMUNICATIONS, vol. 12, no. 1, 17 May 2017 (2017-05-17), pages 85,86
UESUGI, D. ET AL.: "Synthesis, Oxygen radical absorbance capacity, and tyrosinase inhibitory activity of glycosides of resveratrol, pterostilbene and pinostilbene", BIOSCIENCE, BIOTECHNOLOGY, AND BIOCHEMISTRY, vol. 81, no. 2, 19 October 2016 (2016-10-19), pages 226 - 230, XP055470528
ERIKO INUI ET AL.: "Development of ASTALIFT Renewal Products", FUJIFILM RESEARCH & DEVELOPMENT, vol. 58, 2013, pages 19 - 23, XP055470284
YOON, H. S. ET AL.: "Comparative Depigmentation Effects of Resveratrol and Its Two Methyl Analogues in -Melanocyte stimulating Hormone- Triggered B16/F10 Murine Melanoma Cells", PREV. NUTR. FOOD SCI., vol. 21, no. 2, 2016, pages 155 - 159, XP055470286, [retrieved on 20160630]
HAMADA, H. ET AL.: "Pterostilbene and Its Glucoside Induce Type XVII Collagen Expression", NATURAL PRODUCT COMMUNICATIONS, vol. 12, no. 1, 17 May 2017 (2017-05-17), pages 85,86
UESUGI, D. ET AL.: "Synthesis, Oxygen radical absorbance capacity, and tyrosinase inhibitory activity of glycosides of resveratrol, pterostilbene and pinostilbene", BIOSCIENCE, BIOTECHNOLOGY, AND BIOCHEMISTRY, vol. 81, no. 2, 19 October 2016 (2016-10-19), pages 226 - 230, XP055470528
Attorney, Agent or Firm:
SAEGUSA & PARTNERS (JP)
Download PDF:
Previous Patent: MAGNETIC RESONANCE DEVICE AND METHOD
Next Patent: COMPOSITION FOR EXTERNAL USE THAT INCLUDES PTEROSTILBENE GLYCOSIDE
Next Patent: COMPOSITION FOR EXTERNAL USE THAT INCLUDES PTEROSTILBENE GLYCOSIDE